Kyriakidou for AstraZeneca vaccine: Evaluation expected late Wednesday – The official placement of the EMA

The Commission is in close contact with the European Medicines Agency, as the EU Health Commissioner said in a recent post. Stella Kyriakidou. In particular, he pointed out:

“In close contact with the European Medicines Agency on the pharmacovigilance evaluation of the AstraZeneca vaccine. The evaluation is expected late on Wednesday “.

EU: EMA ‘has not yet reached a conclusion’ on AstraZeneca vaccine

The European Medicines Agency (EMA) said in a statement received by the French Agency (AFP) that it was continuing to examine whether the AstraZeneca vaccine against Covid-19 was associated with the rare formation of blood clots, after an official of the organization told the press today that there is such a connection.

The European Regulatory Authority’s Security Committee “has not yet reached a conclusion and the examination is ongoing”, the EMA said in a statement. A decision on the matter will be announced tomorrow or Thursday, it is clarified in the announcement.

“It simply came to our notice then AstraZeneca vaccine against Covid and blood clots “

A senior official of the European Medicines Agency (EMA) says there is a link between AstraZeneca vaccine against Covid and blood clots.

The reason, however, is not clear, he emphasizes. The news is broadcast by the French News Agency.

EMA vaccine chief Marco Cavaleri told the Italian newspaper Il Messaggero that “in my opinion, it is clear that there is a connection with the vaccine”. However, it is not clear what provoked such a reaction. He said that the connection will be confirmed in the next few hours by him European Medicines Agency.

“Cases are extremely rare and the cost-benefit ratio continues to favor vaccines,” said the Coreper Vaccine Strategy Officer, referring to possible side effects.

Referring to the AstraZeneca vaccine against coronavirus, he added: “But now it is increasingly difficult to say that there is no link between the AstraZeneca vaccine and the very rare cases of blood clots associated with low platelet counts.”

Cavalieri stressed, however, that “the relevant assessments of the competent European authorities have not been completed” and that “general instructions will be given during the week”, but “it is difficult to refer to age limits, as some countries have done”.

The head of the European Medicines Agency’s vaccination strategy told Il Messaggero, as reported by the Athens News Agency, that “young women, who have had these clots most of the time, are not affected by the coronavirus in a very serious way. “So in this case, we have to evaluate the cost-benefit ratio.”

“The instructions for this preparation will definitely be updated, with reference to the side effects associated with the vaccine. It will be underlined in a clear way “, Marco Cavalieri emphasizes, finally.

A possible incident in Greece – “Attention to three symptoms”

The president of the National Vaccination Committee Maria Theodoridou, during the briefing on the National Coronavirus Vaccination Scheme, referred once again to the vaccine ΑstraZeneca and the possibility of association with a rare syndrome that combines thrombosis and thrombocytopenia.

“It seems to be more common in women under the age of 55, but cases have occurred across the age range. “The vaccination committee is closely monitoring the issue,” said the chairwoman of the National Vaccination Committee.

He also stressed that “to date there is no documented association with a previous case of thrombosis. Coreper has reported 44 cases, while in Greece in a total of 346,000 doses an episode has been reported to EOF that has been characterized as possible. Early diagnosis leads to early treatment, he said and recommended Attention to symptoms (chest, abdominal pain, headache)».

Ms. Theodoridou pointed out that suspicious symptoms should appear within 28 days of the vaccination and should be reported to a doctor, who must fill in a yellow card and consult a hematologist if he deems it necessary.

It is noted, as stated by the President of the National Vaccination Committee, that among the symptoms may be skin manifestations such as bruising or minor bleeding.